All Stories

  1. Hypothalamic and sex-related hormones in migraine
  2. Smoking and Endothelial Dysfunction
  3. The Therapeutic Impact of New Migraine Discoveries
  4. Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries
  5. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
  6. Board Walk – July 2019
  7. Discovery of CGRP in relation to migraine
  8. Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
  9. Role of pannexin and adenosine triphosphate (ATP) following myocardial ischemia/reperfusion
  10. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
  11. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment
  12. Board Walk – October 2017
  13. Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery
  14. Lipid-soluble cigarette smoking particles induce expression of inflammatory and extracellular-matrix-related genes in rat cerebral arteries